Anlon Healthcare Ltd vs National Peroxide Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 121.35 as of 20 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of National Peroxide Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of National Peroxide Ltd changed from ₹ 331.6 crore on March 2025 to ₹ 331.6 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of National Peroxide Ltd for the Dec '25 is ₹ 69.99 crore as compare to the Sep '25 revenue of ₹ 69.95 crore. This represent the growth of 0.06% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of National Peroxide Ltd for the Dec '25 is ₹ 7.3 crore as compare to the Sep '25 ebitda of ₹ 6.16 crore. This represent the growth of 18.51% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of National Peroxide Ltd changed from ₹ 5.08 crore to ₹ 1.83 crore over 7 quarters. This represents a CAGR of -44.20% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of National Peroxide Ltd changed from 42.81 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About National Peroxide Ltd

National Peroxide Limited (NPL) was formerly incorporated as NPL Chemicals Limited on July 29, 2020, as a Public Limited Company pursuant to a Certificate of Incorporation dated August 5, 2020, issued by the Registrar of Companies, Maharashtra at Mumbai.
Through the Composite Scheme of Arrangement, the name of the Company has been changed to National Peroxide Limited and a fresh Certificate of Incorporation dated January 31, 2024, was issued by the Registrar of Companies, Maharashtra at Mumbai. In 2023, pursuant to the Composite Scheme of Arrangement amongst the Company and Naperol Investments Limited and NPL Chemicals Limited and their respective shareholders and creditors, the Chemical Business of the Company was transferred to NPL Chemicals Limited with effect from April 1, 2022 and Naperol Investments Limited got merged with the Demerged Company i.

FAQs for the comparison of Anlon Healthcare Ltd and National Peroxide Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or National Peroxide Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of National Peroxide Ltd is 228 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and National Peroxide Ltd?

The stock performance of Anlon Healthcare Ltd and National Peroxide Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and National Peroxide Ltd?

As of March 22, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, National Peroxide Ltd stock price is INR ₹398.25.

How do dividend payouts of Anlon Healthcare Ltd and National Peroxide Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and National Peroxide Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.